Paul Tudor Jones II's position in Veracyte is currently worth $1.11M. That's 0.01% of their equity portfolio (1063rd largest holding). The first Veracyte trade was made in Q4 2020. Since then Paul Tudor Jones II bought shares eight more times and sold shares on eight occasions. The stake costed the investor $1.02M, netting the investor a gain of 9.0% so far.